RxDoctor Payments Data

Brenda Castells

Child & Adolescent Psychiatry · Palatka, FLNPI 1366645129

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $767, 2.1 times the $370 reported in 2019.

$2,840in general payments, 2019–2025

Across 145 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$495
  • Johnson & Johnson$316
  • Neurocrine Biosciences, Inc.$298
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$282
  • Sunovion Pharmaceuticals Inc.$260
  • Teva Pharmaceuticals USA, Inc.$215
  • plus $973 from 13 others

What the payments were for

  • Food & beverage$2,840100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,840 in reported general payments places this provider in the 75th percentile of 206 child & adolescent psychiatry providers in Florida.

See all child & adolescent psychiatry providers in Florida

Other child & adolescent psychiatry in Palatka

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →